JP2022503621A5 - - Google Patents
Info
- Publication number
- JP2022503621A5 JP2022503621A5 JP2021511584A JP2021511584A JP2022503621A5 JP 2022503621 A5 JP2022503621 A5 JP 2022503621A5 JP 2021511584 A JP2021511584 A JP 2021511584A JP 2021511584 A JP2021511584 A JP 2021511584A JP 2022503621 A5 JP2022503621 A5 JP 2022503621A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- domain
- binding
- pharmaceutical composition
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724597P | 2018-08-29 | 2018-08-29 | |
| US201862724600P | 2018-08-29 | 2018-08-29 | |
| US62/724,597 | 2018-08-29 | ||
| US62/724,600 | 2018-08-29 | ||
| US201862734950P | 2018-09-21 | 2018-09-21 | |
| US201862734951P | 2018-09-21 | 2018-09-21 | |
| US62/734,951 | 2018-09-21 | ||
| US62/734,950 | 2018-09-21 | ||
| US201962793235P | 2019-01-16 | 2019-01-16 | |
| US62/793,235 | 2019-01-16 | ||
| US201962832830P | 2019-04-11 | 2019-04-11 | |
| US62/832,830 | 2019-04-11 | ||
| US201962890217P | 2019-08-22 | 2019-08-22 | |
| US62/890,217 | 2019-08-22 | ||
| PCT/US2019/048916 WO2020047322A1 (en) | 2018-08-29 | 2019-08-29 | Combination therapies comprising tim-3-based chimeric proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022503621A JP2022503621A (ja) | 2022-01-12 |
| JP2022503621A5 true JP2022503621A5 (https=) | 2022-09-06 |
Family
ID=69643783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511584A Pending JP2022503621A (ja) | 2018-08-29 | 2019-08-29 | Ｔｉｍ－３系キメラタンパク質を含む併用療法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210179689A1 (https=) |
| EP (1) | EP3844185A4 (https=) |
| JP (1) | JP2022503621A (https=) |
| CN (1) | CN112888706A (https=) |
| AU (1) | AU2019328305A1 (https=) |
| CA (1) | CA3109349A1 (https=) |
| IL (1) | IL281123A (https=) |
| MX (1) | MX2021002291A (https=) |
| WO (1) | WO2020047322A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201807625PA (en) * | 2014-11-17 | 2018-10-30 | Genentech Inc | Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists |
| SG11201705844SA (en) * | 2015-02-06 | 2017-08-30 | Heat Biologics Inc | Vector co-expressing vaccine and costimulatory molecules |
| JP6981973B2 (ja) * | 2015-10-01 | 2021-12-17 | ヒート バイオロジクス，インコーポレイテッド | Ｉ型及びｉｉ型細胞外ドメインを異種キメラタンパク質として連結する組成物及び方法 |
| MX2018006181A (es) * | 2015-11-23 | 2018-09-24 | Five Prime Therapeutics Inc | Inhibidores de fgfr2 solos o en combinacion con agentes que estimulan el sistema inmunitario en el tratamiento contra el cancer. |
| US20190367579A1 (en) * | 2017-02-27 | 2019-12-05 | Shattuck Labs, Inc. | Tigit- and light-based chimeric proteins |
-
2019
- 2019-08-29 US US17/265,684 patent/US20210179689A1/en not_active Abandoned
- 2019-08-29 JP JP2021511584A patent/JP2022503621A/ja active Pending
- 2019-08-29 CN CN201980070366.7A patent/CN112888706A/zh active Pending
- 2019-08-29 WO PCT/US2019/048916 patent/WO2020047322A1/en not_active Ceased
- 2019-08-29 AU AU2019328305A patent/AU2019328305A1/en not_active Abandoned
- 2019-08-29 CA CA3109349A patent/CA3109349A1/en active Pending
- 2019-08-29 MX MX2021002291A patent/MX2021002291A/es unknown
- 2019-08-29 EP EP19856345.4A patent/EP3844185A4/en not_active Withdrawn
-
2021
- 2021-02-25 IL IL281123A patent/IL281123A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10766943B2 (en) | Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders | |
| JP2022512541A5 (https=) | ||
| US20200087377A1 (en) | Multifunctional Fusion Protein and Applications Thereof | |
| JP2020530298A5 (https=) | ||
| JP2020508068A5 (https=) | ||
| JP7464525B2 (ja) | 標的療法のためのチェックポイント遮断を組み合わせる二官能性タンパク質 | |
| IL279146B1 (en) | Reverse chimeric universal antigen receptor (RevCAR) expressing immune cells targeting multiple and different antigens, method of making them and use thereof for treating cancer, infections and autoimmune disorders | |
| JP2022511286A5 (https=) | ||
| JP2020506727A5 (https=) | ||
| TW201718646A (zh) | Ｔｉｇｉｔ結合劑和彼之用途 | |
| JP2021512151A5 (https=) | ||
| TW202116811A (zh) | 調節免疫檢查點作為癌症治療的單特異性蛋白質、其醫藥組成物、其核酸、及其用途 | |
| JP7033601B2 (ja) | 抗コチニンキメラ抗原受容体を発現するナチュラルキラー細胞 | |
| JP2022512539A5 (https=) | ||
| JP2021501575A (ja) | 二重特異性抗体並びにその製造方法及び使用方法 | |
| JP2022532430A5 (https=) | ||
| CN114616251B (zh) | 靶向PD-1和TGFβ的重组蛋白 | |
| JP2022503621A5 (https=) | ||
| CN118510794A (zh) | 白细胞介素-12变体和使用方法 | |
| US11866493B2 (en) | Single-chain variable fragment of Met monoclonal antibody and methods of use in CAR T cell therapy | |
| EP4545631A1 (en) | Immune cell expressing immune checkpoint regulator, and use thereof | |
| JP2012025694A (ja) | 癌治療剤 | |
| CA3195627A1 (en) | Il-2/il-15r.beta..gamma. agonist for treating squamous cell carcinoma | |
| RU2021108091A (ru) | Комбинированные виды терапии | |
| WO2026082164A1 (en) | A modified dual-targeting t cell receptor complex and its pharmaceutical application thereof |